Magnetic Resonance Imaging (MRI) examinations frequently involve the use of a contrast agent containing gadolinium. This gadolinium-based contrast can typically be administered to patients with a known allergy to iodine-based contrast agents. The incidence of allergic reactions to gadolinium contrast is considerably lower compared to iodine contrast. Therefore, it is crucial for patients undergoing an MRI examination to clearly disclose any allergies to contrast agents, food, or medications on the provided consent form, ensuring this information is communicated to the preparing technologist.